Targeted therapies: Tivantinib--a cytotoxic drug in MET inhibitor's clothes?

Nat Rev Clin Oncol. 2013 Jul;10(7):372-4. doi: 10.1038/nrclinonc.2013.86. Epub 2013 May 28.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation / drug effects*
  • Humans
  • Proto-Oncogene Proteins c-met / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-met / metabolism*
  • Pyrrolidinones / pharmacology*
  • Quinolines / pharmacology*
  • Tubulin Modulators / pharmacology*

Substances

  • Antineoplastic Agents
  • Pyrrolidinones
  • Quinolines
  • Tubulin Modulators
  • Proto-Oncogene Proteins c-met